LobbyingAbiomed lobbying by quarter
Abiomed's latest lobbying report covers Q4 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Abiomed
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $230K | 3 |
| Q1 2023 | $210K | 3 |
| Q2 2023 | $220K | 3 |
| Q3 2023 | $220K | 3 |
| Q4 2023 | $230K | 3 |
| Q1 2024 | $220K | 3 |
| Q2 2024 | $220K | 2 |
| Q3 2024 | $220K | 2 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $50K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2M · 21 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE21 reports
- HOUSE OF REPRESENTATIVES20 reports
- Health & Human Services, Dept of (HHS)8 reports
- Food & Drug Administration (FDA)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAbiomed | $1.3M | 8 quarters |
| BGR Government Affairs | $690K | 13 quarters |
| Akin Gump Strauss Hauer & Feld | $10K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q3 2025 |
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q3 2025 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q3 2025 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q3 2025 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q3 2025 |
| ROBERT WOOD | Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug | Q3 2025 |
| DANIELLE MITCHELL | Office of Representative Gwen Graham (D-FL), Intern, 8/2016-12/2016 Horizon Therapetuics, Fellow, 6/2017-10/2017 California Life Science Association CLSA), Manager GA, 10/2017-4/2021 | Q2 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q4 2025 | BGR Government Affairs | Under $5,000 |
| 25/10/20for Q3 2025 | BGR Government Affairs | $50K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $50K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $50K |
| 25/01/20for Q4 2024 | BGR Government Affairs | $60K |
| 24/10/21for Q3 2024 | BGR Government Affairs | $60K |
| 24/10/17for Q3 2024 | In-house | $160K |
| 24/07/22for Q2 2024 | BGR Government Affairs | $60K |
| 24/07/17for Q2 2024 | In-house | $160K |
| 24/04/22for Q1 2024 | BGR Government Affairs | $60K |
| 24/04/18for Q1 2024 | In-house | $160K |
| 24/04/12for Q1 2024 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 24/01/22for Q4 2023 | BGR Government Affairs | $60K |
| 24/01/19for Q4 2023 | In-house | $170K |
| 24/01/19for Q4 2023 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 23/10/20for Q3 2023 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 23/10/20for Q3 2023 | BGR Government Affairs | $60K |
| 23/10/17for Q3 2023 | In-house | $160K |
| 23/07/20for Q2 2023 | BGR Government Affairs | $60K |
| 23/07/20for Q2 2023 | Akin Gump Strauss Hauer & Feld | Under $5,000 |